Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis
Background/Objectives: Differential diagnosis of sudden cardiac death (SCD) remains challenging, particularly in cases lacking evident structural abnormalities. Cardiac markers have been proposed as useful tools for this differentiation in forensic contexts. However, key issues include the influence...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/1/193 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832588973029982208 |
|---|---|
| author | Matteo Antonio Sacco Valerio Riccardo Aquila Saverio Gualtieri Roberto Raffaele Maria Cristina Verrina Lucia Tarda Santo Gratteri Isabella Aquila |
| author_facet | Matteo Antonio Sacco Valerio Riccardo Aquila Saverio Gualtieri Roberto Raffaele Maria Cristina Verrina Lucia Tarda Santo Gratteri Isabella Aquila |
| author_sort | Matteo Antonio Sacco |
| collection | DOAJ |
| description | Background/Objectives: Differential diagnosis of sudden cardiac death (SCD) remains challenging, particularly in cases lacking evident structural abnormalities. Cardiac markers have been proposed as useful tools for this differentiation in forensic contexts. However, key issues include the influence of postmortem interval (PMI) on marker stability and the limitations of traditional approaches that focus on pericardial fluid, which requires invasive sampling compared to peripheral blood. This study aimed to evaluate the potential of cardiac markers in peripheral blood for diagnosing SCD, addressing methodological concerns related to PMI, hemolysis, and sample handling. Methods: This study analyzed 5 cardiac markers (creatine kinase-MB [CK-MB], myoglobin, troponin I [TnI], BNP, and D-dimer) in peripheral blood samples from 42 autopsied cadavers, divided into an SCD group and a control group. Marker levels were quantified using immunofluorescence, with cases meticulously selected to exclude confounding factors such as chronic diseases, pulmonary thromboembolism, and drowning. The study also accounted for potential degradation due to PMI, and evaluated the accuracy of point-of-care testing (POCT) in forensic samples. Results: The study identified statistically significant differences in myoglobin and TnI levels between the SCD group and the control group, though myoglobin’s diagnostic reliability remains limited due to its lack of specificity for myocardial injury. TnI emerged as a more robust marker for SCD. Contrary to prior concerns, PMI showed no significant correlation with marker levels in samples handled without freeze–thaw cycles. Issues related to hemolysis were addressed, and no significant effects were observed from resuscitation maneuvers. Conclusions: This study supports the potential use of cardiac markers, particularly TnI, in peripheral blood for postmortem SCD diagnosis, emphasizing the importance of rapid and systematic analysis to minimize hemolysis-related variability. While further validation is needed to confirm these findings, this approach offers a less invasive, economical, and practical method for forensic investigations. |
| format | Article |
| id | doaj-art-59ede607004c4bd186fc3b6b66cb4ed9 |
| institution | Kabale University |
| issn | 2227-9059 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj-art-59ede607004c4bd186fc3b6b66cb4ed92025-01-24T13:24:21ZengMDPI AGBiomedicines2227-90592025-01-0113119310.3390/biomedicines13010193Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker AnalysisMatteo Antonio Sacco0Valerio Riccardo Aquila1Saverio Gualtieri2Roberto Raffaele3Maria Cristina Verrina4Lucia Tarda5Santo Gratteri6Isabella Aquila7Institute of Legal Medicine, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyDepartment of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyInstitute of Legal Medicine, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyInstitute of Legal Medicine, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyInstitute of Legal Medicine, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyInstitute of Legal Medicine, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyInstitute of Legal Medicine, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyInstitute of Legal Medicine, Department of Medical and Surgical Sciences, “Magna Graecia” University, 88100 Catanzaro, ItalyBackground/Objectives: Differential diagnosis of sudden cardiac death (SCD) remains challenging, particularly in cases lacking evident structural abnormalities. Cardiac markers have been proposed as useful tools for this differentiation in forensic contexts. However, key issues include the influence of postmortem interval (PMI) on marker stability and the limitations of traditional approaches that focus on pericardial fluid, which requires invasive sampling compared to peripheral blood. This study aimed to evaluate the potential of cardiac markers in peripheral blood for diagnosing SCD, addressing methodological concerns related to PMI, hemolysis, and sample handling. Methods: This study analyzed 5 cardiac markers (creatine kinase-MB [CK-MB], myoglobin, troponin I [TnI], BNP, and D-dimer) in peripheral blood samples from 42 autopsied cadavers, divided into an SCD group and a control group. Marker levels were quantified using immunofluorescence, with cases meticulously selected to exclude confounding factors such as chronic diseases, pulmonary thromboembolism, and drowning. The study also accounted for potential degradation due to PMI, and evaluated the accuracy of point-of-care testing (POCT) in forensic samples. Results: The study identified statistically significant differences in myoglobin and TnI levels between the SCD group and the control group, though myoglobin’s diagnostic reliability remains limited due to its lack of specificity for myocardial injury. TnI emerged as a more robust marker for SCD. Contrary to prior concerns, PMI showed no significant correlation with marker levels in samples handled without freeze–thaw cycles. Issues related to hemolysis were addressed, and no significant effects were observed from resuscitation maneuvers. Conclusions: This study supports the potential use of cardiac markers, particularly TnI, in peripheral blood for postmortem SCD diagnosis, emphasizing the importance of rapid and systematic analysis to minimize hemolysis-related variability. While further validation is needed to confirm these findings, this approach offers a less invasive, economical, and practical method for forensic investigations.https://www.mdpi.com/2227-9059/13/1/193sudden cardiac deathscardiac markerstroponinsforensic sciences |
| spellingShingle | Matteo Antonio Sacco Valerio Riccardo Aquila Saverio Gualtieri Roberto Raffaele Maria Cristina Verrina Lucia Tarda Santo Gratteri Isabella Aquila Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis Biomedicines sudden cardiac deaths cardiac markers troponins forensic sciences |
| title | Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis |
| title_full | Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis |
| title_fullStr | Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis |
| title_full_unstemmed | Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis |
| title_short | Quantification of Myocardial Biomarkers in Sudden Cardiac Deaths Using a Rapid Immunofluorescence Method for Simultaneous Biomarker Analysis |
| title_sort | quantification of myocardial biomarkers in sudden cardiac deaths using a rapid immunofluorescence method for simultaneous biomarker analysis |
| topic | sudden cardiac deaths cardiac markers troponins forensic sciences |
| url | https://www.mdpi.com/2227-9059/13/1/193 |
| work_keys_str_mv | AT matteoantoniosacco quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis AT valerioriccardoaquila quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis AT saveriogualtieri quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis AT robertoraffaele quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis AT mariacristinaverrina quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis AT luciatarda quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis AT santogratteri quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis AT isabellaaquila quantificationofmyocardialbiomarkersinsuddencardiacdeathsusingarapidimmunofluorescencemethodforsimultaneousbiomarkeranalysis |